9 Hrs
المصدر:
The Guardian
The Guardian
جاهز للتشغيل
جاهز للتشغيل
A new study shows that a coronary sinus reducer (CSR) implant significantly reduces chest pain in 75% of patients with refractory angina. The small device, implanted via minimally invasive surgery, helps redirect blood flow to reduce symptoms in patients who have not benefited from standard treatments. While promising, the treatment remains experimental, and further trials and NHS approval are needed before wider adoption.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading